Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)

CUSIP: 471871202

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+12,456,253
Put/Call ratio
14%
SEC-reported price per share
$29.36
Number of holders
56
Value change
+$364,621,578
Number of buys
55
Open additional details 1 more signal available
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
33,341,578

Security key

471871202

Report period

Q1 2024

Institutions

56

Top holders

10

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Velan Capital Investment ...
Disclosed value leader
Ally Bridge Group (NY) LLC
Comparable rows
0/15
Latest evidence
08 Feb 2024
3/4/5 13F Highest disclosed value: $28,871,522 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Ally Bridge Group (NY) LLC has the largest disclosed position value at $28.87M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ally Bridge Group (NY) LLC's linked filing trail.
Disclosed position value Top 5
Velan Capital Investment Manageme... $18.57M
Carlyle Group Inc. $13.81M
Qiming U.S. Healthcare Fund II, L.P. $5.53M
ROCHE HOLDING LTD $2.95M
Amplitude Healthcare Holdings LLC $1.49M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Velan Capital Investment Management LP
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$18,568,073
1,433,828 shares
— 08 Feb 2024
Carlyle Group Inc.
3/4/5 13F
Former 10% Owner · Company
—
denominator unverified
$13,807,148
1,066,189 shares
— 08 Feb 2024
Qiming U.S. Healthcare Fund II, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$5,525,844
8,519,648 shares
— 27 Jan 2023
ROCHE HOLDING LTD
3/4/5
10%+ Owner
—
denominator unverified
$2,950,874
4,549,606 shares
— 25 Jan 2023
Amplitude Healthcare Holdings LLC
3/4/5
10%+ Owner
—
denominator unverified
$1,491,780
2,300,000 shares
— 24 Sep 2021
Abingworth LLP
3/4/5
10%+ Owner
—
denominator unverified
—
78,045 shares
— 21 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
56
Shares
12,950,959
Rows available
56
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
56
Q1 2024 holders
56
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .